openPR Logo
Press release

Elevating Hemostasis: Prothrombin Complex Concentrates Market Poised to Achieve a Valuation of $1.2 Billion by 2033

08-08-2023 01:20 PM CET | Health & Medicine

Press release from: Future Market Insights

Elevating Hemostasis: Prothrombin Complex Concentrates

Demand for prothrombin complex concentrates market is expected to reach US$ 772.0 million in 2023 and US$ 1.2 billion in 2033. As the market for prothrombin complex concentrates is expected to grow at a steady CAGR of 4.1%, the United Kingdom, the United States, China, and India are expected to emerge as major producers.

The global Prothrombin Complex Concentrates market is expected to grow rapidly over the next decade, reaching a value of US$ 1.2 billion by 2033. According to market analysts, the market will be worth US$ 772.0 million in 2023, indicating a steady rise.

Take the first step towards enhanced performance and unmatched efficiency today! Request Sample Now : https://www.futuremarketinsights.com/reports/sample/rep-gb-7032

Prothrombin Complex Concentrates (PCC) are critical therapeutic agents used to treat bleeding disorders, primarily in patients with deficiencies in clotting factors. They play a vital role in managing hemorrhages caused by congenital coagulation factor deficiencies, liver diseases, and vitamin K antagonists. The increasing prevalence of bleeding disorders, coupled with rising surgical procedures and trauma cases, is driving the demand for PCC.

Key factors contributing to the anticipated growth of the Prothrombin Complex Concentrates market include advancements in the healthcare infrastructure, a rise in awareness about bleeding disorders, and the development of innovative PCC formulations. Additionally, a growing geriatric population and the increasing incidence of hemophilia and other clotting disorders are expected to fuel market expansion.

A new study by the company titled 'Prothrombin Complex Concentrates Market: Global Industry Analysis 2013 to 2017 and Opportunity Assessment 2018 to 2028', has listed out the key points being considered by the companies operating in the prothrombin complex concentrates market to emerge and stay sustainably profitable in the long run. The North America prothrombin complex concentrates market is projected to expand at a CAGR of 3.5% over the forecast period. North America and Western Europe are expected to be dominant markets for prothrombin complex concentrates, as most of the manufacturing facilities of prothrombin complex concentrates are located in these regions. However, the increasing demand for optimized & sustainable healthcare in countries of Asia Pacific, such as China and India, and of Middle-East is expected to fuel the growth of the prothrombin complex concentrates market.

The report finds the players operating in the market are laying emphasis on improving treatment options for patients with hemophilia B.
Treatment with prothrombin complex concentrates is an economical option for warfarin reversal. It is has been observed that the treatment with prothrombin complex concentrates is the most economical option as it minimizes the hospital stay and laboratory costs. Direct healthcare costs including drug and hospital costs in Europe are approximately US$ 400,000 for prothrombin complex concentrates, whereas for warfarin withdrawal therapy, it was approximated US$ 1,200,000.

Manufacturers tend to depend on plasma as a primary precursor to manufacture prothrombin complex concentrates, and in the past, they relied on third-party sources for plasma. Manufacturers are now opening their own plasma collection banks to reduce dependence on third-party sources. This trend has been observed to have grown since 2013. The key players operating in the market, such as CSL Behring & Shire, have scaled up their focus on depending on their own sources for plasma.

Keytakeways:

1.Essential Hemostatic Support: Prothrombin Complex Concentrates (PCC) play a vital role in providing rapid and effective hemostatic support for individuals with clotting disorders.

2.Swift Reversal: PCC offers a rapid reversal of anticoagulant effects, making it crucial in emergency situations, such as bleeding events or urgent surgical interventions.

3.Diverse Indications: Widely used across diverse indications including hemophilia, vitamin K deficiency, and warfarin-related bleeding, PCC demonstrates its versatility.

4.Improved Patient Outcomes: PCC's ability to rapidly restore normal clotting factors contributes to improved patient outcomes by reducing bleeding risks.

5.Convenience in Dosage: PCC's concentrated form allows for lower volumes of administration, minimizing fluid overload concerns during treatment.

6.Precise Coagulation Restoration: PCC's specific coagulation factor composition ensures targeted and accurate restoration of clotting factors.

7.Advances in Safety: Ongoing advancements in PCC manufacturing processes enhance safety profiles, reducing the risk of adverse events.

8.Broader Accessibility: Expanding awareness and adoption of PCC globally facilitate improved accessibility to life-saving clotting factor therapy.

Insights Designed for You: Customize Your Exclusive Report Today : https:/www.futuremarketinsights.com/customization-available/rep-gb-7032

Competitive Environment :
Companies use a variety of strategies to increase their market share. These are some examples:
Strategic alliances and collaborations: Many businesses are forming alliances and collaborations with other businesses in order to broaden their market reach, develop new products, and improve their manufacturing capabilities. For example, Sanquin and Octapharma announced a long-term collaboration in 2021 to develop and manufacture prothrombin complex concentrates for the treatment of bleeding disorders.

Product differentiation and innovation: Many companies are working to create new and innovative prothrombin complex concentrates that provide improved efficacy, safety, and patient convenience. CSL Behring, for example, received FDA approval for its Idelvion product in 2020, which is a longer-acting factor IX therapy that can be administered less frequently than traditional prothrombin complex concentrates.

Market expansion: Many businesses strive to expand their market.

Unlock your investment potential today! Gain exclusive insights and expert analysis with our comprehensive analyst report : https://www.futuremarketinsights.com/ask-question/rep-gb-7032

Key Segments :

Distribution Channel:
•Compound Pharmacies
•Retail Pharmacies
•Hospital Pharmacies

Region:
•North America
•Latin America
•Europe
•APEJ
•Middle East & Africa (MEA)

About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Report :
https://www.futuremarketinsights.com/reports/prothrombin-complex-concentrate-market

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Elevating Hemostasis: Prothrombin Complex Concentrates Market Poised to Achieve a Valuation of $1.2 Billion by 2033 here

News-ID: 3158261 • Views:

More Releases from Future Market Insights

Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered by Advanced Imaging and Office Tech
Polygon Mirror Scanner Motor Market Set to Hit USD 88.5 Million by 2035, Powered …
The global polygon mirror scanner motor market is experiencing robust growth, forecasted to rise from USD 55.9 million in 2025 to USD 88.5 million by 2035, which represents a nearly 1.6-fold increase over the assessment period. This remarkable expansion is shaped by the widespread adoption of next-generation scanning technologies and the rapid digital transformation across the printing and office equipment industries. As businesses renew their focus on speed, accuracy, and
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven by Polymer and Textile Demand
Global p-Hydroxybenzoic Acid Market to Approach USD 400 Million by 2035, Driven …
The global p-Hydroxybenzoic Acid (PHBA) market is entering a new era of growth, expected to rise from USD 213.0 million in 2025 to USD 399.8 million by 2035, showcasing a compound annual growth rate of 6.5%. This surge is underpinned by PHBA's flourishing adoption in polymer synthesis, textile processing, and supporting industries seeking high-performance and sustainable chemical solutions. As organizations shift towards advanced materials with enhanced durability, thermal stability, and
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 as Manufacturers Innovate for Green Industries
Sustainable Growth Drives Castor Oil Polyol Market to USD 418.8 Million by 2035 …
The castor oil polyol market is set to reshape the landscape of bio-based chemicals, growing from a value of USD 254.7 million in 2025 to USD 418.8 million by 2035. This represents a robust CAGR of 5.1% over the decade, with expansion driven by surging demand across chemical, automotive, construction, and coatings sectors. The market's early growth, spanning 2021 to 2025, reflects steady adoption as sustainable polyols substitute petroleum-based alternatives,
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smart Fleet Innovations
Global Fifth Wheel Coupling Market to Hit USD 1.2 Billion by 2035 Driven by Smar …
The global Fifth Wheel Coupling Market continues to evolve as the logistics and transport sectors demand more efficient, safe, and smart towing systems. Valued at USD 547.3 million in 2020 and reaching USD 672.6 million by 2024, the market is projected to expand at a 6.0% CAGR from 2025 to 2035, ultimately achieving a valuation of USD 1,238.6 million. At the heart of this growth lies the critical role of fifth

All 5 Releases


More Releases for PCC

Global Coated Precipitated Calcium Carbonate (PCC) Market 2024 Research Report
Global Coated Precipitated Calcium Carbonate (PCC) Market Coated precipitated calcium carbonate is calcium carbonate powder after modification treatment. A special coating structure is formed on the surface, which can significantly improve the dispersion and affinity in high polymer matrix such as polyolefin, and can be combined with high The interfacial interaction between the polymer matrix can improve the impact strength of the product. It is a kind of incremental filling additive
Precipitated Calcium Carbonate (PCC) Market: Competitive Dynamics & Global Outlo …
Precipitated calcium carbonate (PCC) is an innovative product derived from lime, which has many industrial applications. PCC is made by hydrating high-calcium quicklime and then reacting the resulting slurry, or "milk-of-lime", with carbon dioxide. LPI (LP Information)' newest research report, the "Precipitated Calcium Carbonate (PCC) Industry Forecast" looks at past sales and reviews total world Precipitated Calcium Carbonate (PCC) sales in 2022, providing a comprehensive analysis by region and market sector
Technology Evolution on Prothrombin Complex Concentrate (PCC) Market
According to the Fortune Business Insights report, titled "Prothrombin Complex Concentrate (PCC) Market Size, Share and Industry Analysis By Product Type (3-factor PCC, 4-factor PCC), By Application (Congenital and Acquired Coagulation Factor deficiency), By End User (Hospitals, Ambulatory Surgical Centers), and Regional Forecast 2018-2025", the market value stood at USD 536.3 million in 2017. The report also contains a bird's eye-view analysis of the overall industry outlook and a worm's
Global Precipitated Calcium Carbonate (PCC) Market Research Report 2018-2023
Global Precipitated Calcium Carbonate (PCC) Market is an inventive item gotten from lime, which has numerous modern applications. PCC is made by hydrating high-calcium quicklime. This report centers on the Global Precipitated Calcium Carbonate (PCC) Market is in the Global market, particularly in North America, Europe and Asia-Pacific, South America, Middle East, and Africa. This report orders the market dependent on producers, locales, type, and application. Get sample copy of the
Global Chlorobenzenes Market 2018-2025 Chirag Organics, PCC, Lanxess
A detailed market study on "Global Chlorobenzenes Market" examines the performance of the Chlorobenzenes market. It encloses an in-depth Research of the Chlorobenzenes market state and the competitive landscape globally. This report analyzes the potential of Chlorobenzenes market in the present and the future prospects from various angles in detail. The Global Chlorobenzenes Market 2018 report includes Chlorobenzenes market Size, Revenue, market Share, Chlorobenzenes industry volume, market Trends, Chlorobenzenes Growth aspects.
Global Nonyl Phenol Market 2017 - Dover Chemical, PCC SYNTEZA
The report entitled Global Nonyl Phenol Market 2017 presents key insights into the global Nonyl Phenol market along with the latest up-to-date industry details and forthcoming Nonyl Phenol industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability. Report Keynotes: The main motive of the report on "Global Nonyl Phenol Market 2017" is to study comprehensive details of the market